Skip to content

Zai Lab Ltd

ZLAB· NasdaqCore metricsCIK 1704292

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -1.48%
Market cap
$29.29B
1.12B shares
Filings
743
$107.65M
Q3 2026+15.3% FY25 yoy
-$46.14M
Q3 2026N/M FY25 yoy
-$62.98M
Q3 2026N/M FY25 yoy
-$136.64M
Q3 2026derivedN/M FY25 yoy
-$0.04
Q3 2026N/M FY25 yoy
$549.66M
Q3 2026+51.1% FY25 yoy
$29.29B
—
66.7×
52.0×
-0.56%
—

Twelve months to Sep 30, 2026 · derived

Price

$26.05+18.57%+$4.08past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$460.16MFY 2025
$460.16M0FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$460,156,000reported
FY 20242024-12-31$398,988,000reported
FY 20232023-12-31$266,719,000reported
FY 20222022-12-31$212,672,000reported
FY 20212021-12-31$144,105,000reported
FY 20202020-12-31$48,958,000reported
FY 20192019-12-31$12,985,000reported
FY 20182018-12-31$129,000reported

Segments

Products
Revenue by Products, FY2018 to FY2025FY2018ZEJULA · FY2018 · $129.00KFY2019ZEJULA · FY2019 · $6.63MOPTUNE · FY2019 · $6.36MFY2020ZEJULA · FY2020 · $32.14MOPTUNE · FY2020 · $16.42MQINLOCK · FY2020 · $402.00KOther · FY2020 · $402.00KFY2021ZEJULA · FY2021 · $93.58MNUZYRA · FY2021 · $3.00KOPTUNE · FY2021 · $38.90MQINLOCK · FY2021 · $11.62MFY2022ZEJULA · FY2022 · $145.19MNUZYRA · FY2022 · $5.20MOPTUNE · FY2022 · $47.32MQINLOCK · FY2022 · $14.96MFY2023ZEJULA · FY2023 · $168.84MVYVGART / VYVGART Hytrulo · FY2023 · $10.01MNUZYRA · FY2023 · $21.66MOPTUNE · FY2023 · $46.97MQINLOCK · FY2023 · $19.24MOther · FY2023 · $10.01MFY2024ZEJULA · FY2024 · $187.08MVYVGART / VYVGART Hytrulo · FY2024 · $93.64MNUZYRA · FY2024 · $43.20MOPTUNE · FY2024 · $40.48MQINLOCK · FY2024 · $28.83MXACDURO · FY2024 · $3.31MAUGTYRO · FY2024 · $1.09MFY2025ZEJULA · FY2025 · $189.04MVYVGART / VYVGART Hytrulo · FY2025 · $94.20MNUZYRA · FY2025 · $60.84MOPTUNE · FY2025 · $48.33MQINLOCK · FY2025 · $35.61MXACDURO · FY2025 · $22.91MAUGTYRO · FY2025 · $5.54MOther · FY2025 · $717.00K
LineFY2025ShareChange
ZEJULA$189.04M41%+1.0%
VYVGART / VYVGART Hytrulo$94.20M21%+0.6%
NUZYRA$60.84M13%+40.8%
OPTUNE$48.33M11%+19.4%
QINLOCK$35.61M7.8%+23.5%
XACDURO$22.91M5.0%+593.3%
AUGTYRO$5.54M1.2%+409.0%
Other$717.00K0.2%—
Total$457.18M

From the 10-K filed Feb 26, 2026ZLAB

Pharmaceutical preparations

Zai Lab Ltd is the 58th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR